Date: 2016-04-11
Type of information: Resignation
Compound:
Company: Auspherix (Australia) Auspherix Limited (UK)
Therapeutic area: Infectious diseases
Type agreement: resignation
Action mechanism:
Disease:
Details: * On April 11, 2016, Auspherix announced that the co-founder of Auspherix Ltd. and VP Biology, Dr Dagmar Alber, has left the business to pursue new opportunities. Dagmar's expertise and passion has been pivotal to Auspherix's success.
Financial terms:
Latest news:
